Viemed Healthcare, Inc. (NASDAQ: VMD) reported first-quarter 2026 results that highlight improving growth quality beyond just scale, according to an update from Stonegate Capital Partners. The company's revenue mix is shifting away from its traditional ventilator rental business toward higher-growth areas such as sleep, resupply, and maternal health, which are contributing to better free cash flow (FCF) conversion and capital efficiency.
Key financial metrics showed significant improvement: cash flow from operations (CFFO) increased to $8.1 million from $2.9 million in the same period last year, while trailing twelve-month (TTM) free cash flow rose to $36.3 million from $23.3 million at year-end 2025. This stronger FCF conversion is attributed to the scaling of sleep, resupply, and maternal health operations, which require less capital intensity compared to the legacy ventilator business.
The revenue mix has notably shifted. Ventilator rentals declined to 46.9% of total revenue from 54.4% in the prior year period, while commercial payors increased to 23% from 17%. Sleep and resupply remain the clearest growth drivers: PAP (positive airway pressure) patients increased 57% year-over-year to 35,938, new patient starts grew 42%, and resupply patients increased 47% year-over-year.
Ventilation appears to be navigating the NCD (National Coverage Determination) transition, with better new-start activity and improving compliance. However, turnover continues to pressure census levels. The broader mix shift is helping to offset these pressures and drive overall financial improvement.
Stonegate Capital Partners, which provides the coverage update, noted that the improving growth quality is a positive sign for investors. The full announcement, including downloadable images and bios, is available here.
